282 related articles for article (PubMed ID: 24566401)
21. Comparison of the diagnostic accuracy of 99 m-Tc-MDP bone scintigraphy and 18 F-FDG PET/CT for the detection of skeletal metastases.
Chang CY; Gill CM; Joseph Simeone F; Taneja AK; Huang AJ; Torriani M; Bredella MA
Acta Radiol; 2016 Jan; 57(1):58-65. PubMed ID: 25533313
[TBL] [Abstract][Full Text] [Related]
22. Use of FDG PET-CT in prostate lesion diagnosis.
Radiol Technol; 2014; 85(5):546M-547M. PubMed ID: 24806072
[No Abstract] [Full Text] [Related]
23. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
24. The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
Yi C; Yu D; Shi X; Zhang X; Luo G; He Q; Zhang X
Nucl Med Commun; 2016 Mar; 37(3):239-46. PubMed ID: 26588068
[TBL] [Abstract][Full Text] [Related]
25. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
Moragas M; Soler M; Riera E; García JR
Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
[TBL] [Abstract][Full Text] [Related]
26. Primary Prostatic Extragastrointestinal Stromal Tumor on 18F-FDG PET/CT.
Liu Y; Xu B
Clin Nucl Med; 2016 Mar; 41(3):224-6. PubMed ID: 26402134
[TBL] [Abstract][Full Text] [Related]
27. Unusual lymph node metastases of prostate cancer detected by 18F-fluorocholine PET/CT.
Pinaquy JB; Allard JB; Cornelis F; Pasticier G; De Clermont H
Clin Nucl Med; 2015 Apr; 40(4):e255-7. PubMed ID: 25674860
[TBL] [Abstract][Full Text] [Related]
28. Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT.
Codreanu I; Zhuang H; Alavi A; Torigian DA
Clin Nucl Med; 2012 Jun; 37(6):623-4. PubMed ID: 22614206
[TBL] [Abstract][Full Text] [Related]
29. Coexistent Superscan and Lincoln Sign on Bone Scintigraphy.
Kulkarni M; Soni A; Shetkar S; Amer M; Mulavekar A; Joshi P
Clin Nucl Med; 2017 Aug; 42(8):630-632. PubMed ID: 28525460
[TBL] [Abstract][Full Text] [Related]
30. Utility of 18F-fluoride PET/CT and 18F-FDG PET/CT in the detection of bony metastases in heightened-risk head and neck cancer patients.
Chan SC; Wang HM; Ng SH; Hsu CL; Lin YJ; Lin CY; Liao CT; Yen TC
J Nucl Med; 2012 Nov; 53(11):1730-5. PubMed ID: 22961077
[TBL] [Abstract][Full Text] [Related]
31. Detection of solitary humeral metastasis from pancreatic adenocarcinoma with F-18 FDG PET/CT.
Kim J; Quon A; Humke E; Ford JM; Koong AC
Clin Nucl Med; 2009 May; 34(5):312-3. PubMed ID: 19387214
[No Abstract] [Full Text] [Related]
32. Positive [11C]choline and negative [18F]FDG with positron emission tomography in recurrence of prostate cancer.
Picchio M; Landoni C; Messa C; Gianolli L; Matarrese M; De Cobelli F; Maschio AD; Fazio F
AJR Am J Roentgenol; 2002 Aug; 179(2):482-4. PubMed ID: 12130458
[No Abstract] [Full Text] [Related]
33. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Fricke E; Machtens S; Hofmann M; van den Hoff J; Bergh S; Brunkhorst T; Meyer GJ; Karstens JH; Knapp WH; Boerner AR
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):607-11. PubMed ID: 12589476
[TBL] [Abstract][Full Text] [Related]
35. Unusual Bone Superscan, MIBG Superscan, and 68Ga DOTATATE PET/CT in Metastatic Pheochromocytoma.
Tan TH; Wong TH; Hassan SZ; Lee BN
Clin Nucl Med; 2015 Nov; 40(11):867-8. PubMed ID: 26252329
[TBL] [Abstract][Full Text] [Related]
36. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
Goineau A; Colombié M; Rousseau C; Sadot-Lebouvier S; Supiot S
Clin Nucl Med; 2015 Aug; 40(8):670-1. PubMed ID: 26018683
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-MDP bone scintigraphy and 18F-FDG positron emission tomography in lung and prostate cancer patients: different affinity between lytic and sclerotic bone metastases.
Garcia JR; Simo M; Perez G; Soler M; Lopez S; Setoain X; Lomeña F
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1714. PubMed ID: 14625662
[No Abstract] [Full Text] [Related]
38. C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.
Yu EY; Muzi M; Hackenbracht JA; Rezvani BB; Link JM; Montgomery RB; Higano CS; Eary JF; Mankoff DA
Clin Nucl Med; 2011 Mar; 36(3):192-8. PubMed ID: 21285676
[TBL] [Abstract][Full Text] [Related]
39. 18F-FDG PET/CT Demonstrated the Multiple Myeloma From Prostate.
Cheng A; Liping F; Wang X; Zhao L; Yang J
Clin Nucl Med; 2016 Apr; 41(4):328-30. PubMed ID: 26562573
[TBL] [Abstract][Full Text] [Related]
40. Lytic Bony Lesions On 18 F-FDG PET-CT Versus 99m Tc MDP Bone Scan.
Rasheed N; Razi M
J Pak Med Assoc; 2023 Oct; 73(10):2121-2122. PubMed ID: 37876088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
